1/40
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Neoplasia
Abnormal mass of tissue
Incisional Biopsy
Removal of small portion of tumor
Excisional Biopsy
Most important type of biopsy which allows to assess the extent of spread
Staging
Defined as the extent of disease valuated by a variety of noninvasive and invasive diagnostic tests and procedures
Clinical Staging
Based on physical examination, radiographs, isotopic scans, CT scans, and other imaging procedures
Pathologic Staging
Takes into account information obtained during a surgical procedure
Pathologic Staging
Includes histologic examination of all tissues removed during the surgical procedure
Localized
Exhibiting spread outside of the organ of origin to regional but not distant sites
Metastatic
Spread outside of the organ of origin to distant sites
Pierre Denoix
Developed TNM Staging
1940
Year Pierre Denoix developed TNM staging
International Union Against Cancer and American Joint Committee on Cancer
Adopted the TNM system in the 1950s
1990s
Importance of TNM staging was heightened by the mandatory requirement that Commission on Cancer-approved hospitals use the UICC or AJCC TNM system as the major language for cancer reporting
Tx
Primary tumor cannot be assessed
T0
No evidence of primary tumor
Tis
Carcinoma in situ
Nx
Regional lymph nodes cannot be assessed
N0
No regional lymph nodes metastasis
Mx
Distant metastasis cannot be assessed
M0
No distant metastasis
M1
Distant metastasis
Retreatment Classification
Assigned when further treatment (such as chemotherapy) is planned for a cancer that recurs after a disease-free interval
rTNM
Means recurrent tumor
Autopsy Classification
Occurs when classification of a cancer by postmortem examination is done after the death of a patient (cancer was not evident prior to death)
Stage 0
This stage is of a tumor of microscopic size (carcinoma in situ)
Stage I
Stage for the tumor confined to the organ of origin (cancers are localized to one part of the body)
Stage II
Stage for local spread, not interfering with surgical removal
Stage III
Stage for fixation to the surrounding structures
Stage IV
Stage for distant metastasis
Stage Grouping
The various permutations of T, N, and M scores (sometimes including tumor histologic grade G) are then broken into stages, usually designated by the roman numerals I through IV
Stage A
Invasion of submucosa, five year survival rate of 53.7%
53.7%
Five-year survival rate percentage for stage A
Stage BI
Superficial half of the muscle, 52.6%
52.6%
Survival rate of stage BI
Stage B2
Deep half of muscle, 28.6%
28.6%
% survival rate of stage B2
Stage C
Perivesical tissues, 17.9%
17.9%
% survival rate of stage C
Stage A
Tumor restricted to the wall of the bowel, with a five-year survival rate of 90%
Stage B
With invasion through the wall into the peritoneum or perirectal fat, 65% survival rate
Stage C
Regional lymph node metastases, 20% survival rate